fiercehealthcare - Kaiser Foundation Health Plan has agreed to a settlement with the Department of Labor that resolves multiple investigations into access for mental health and substance abuse services.
#healthcare #publichealth #governmentpolicy
Friday, February 13, 2026, 10:22 pm / permalink 19160 / 4 stories in 4 wks
medicalxpress - A monthlong nurses strike in New York City is coming to an end, but not for everyone.
Friday, February 13, 2026, 6:22 pm / permalink 19158 / 4 stories in 4 wks
fiercehealthcare - At the 2026 Annual Meeting for the health IT office at HHS, officials announced a massive spike in the number of health records shared through the government-backed TEFCA initiative. The number seems to reflect the heavy focus Trump's HHS has put on digit…
#healthcare #publichealth #governmentpolicy #digitalhealth
Friday, February 13, 2026, 12:22 pm / permalink 19136 / 4 stories in 4 wks
Kelly Gooch / beckershospitalreview - A federal judge in the Northern District of Illinois granted a temporary restraining order Feb. 12 blocking the Trump administration from terminating more than $600 million in CDC-administered public health grants to California, Colorado, Illinois and Min…
#healthcare #publichealth #governmentpolicy #cdc
Friday, February 13, 2026, 10:22 am / permalink 19130 / 4 stories in 4 wks
Baris R. Mutlu / nature - Nature Medicine, Published online: 12 February 2026; doi:10.1038/s41591-026-04207-xThe authors developed a microfluidic device, FIND-Chip, designed to automate and enhance oocyte recovery from follicular fluid, a process traditionally done manually. When …
#healthcare #biotech #infanthealth
Friday, February 13, 2026, 9:23 am / permalink 19125 / 4 stories in 4 wks
HIMSS 2026 pushes real‑time data, cloud and interoperability playbook 14 stories in 16.5 hours
Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma 3 stories in 17.5 hours
Vitamin D trial shows reduced long‑COVID risk but no severity benefit 2 stories in 19.5 hours
Atezolizumab added to chemoradiation fails to improve limited‑stage SCLC survival 4 stories in 20.5 hours
FDA approves leucovorin for rare folate disorder despite autism hype 4 stories in 32.5 hours
HORMAD1 emerges as a potential target in triple‑negative breast cancer 4 stories in 45.5 hours
Alfasigma pays $300M to GSK for linerixibat rights, expanding liver-disease portfolio 2 stories in 48.5 hours
Roche’s hoped‑for breast cancer pill fails crucial first‑line trial 5 stories in 49.5 hours
Novo Nordisk and Hims bury the hatchet and carve a deal 3 stories in 54.5 hours
AI improves UK breast-screening detection by about 10% 5 stories in 54.5 hours
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.
Bluesky: